Add BrightSurf on Google Email

Suffocating cancer cells

Researchers have developed a synthetic drug that stops cancer cells from producing energy by blocking oxygen conversion. The tiny hairs formed by the drug's molecules can kill even aggressive and untreatable cancer cells within four hours.

SourceMax Planck Institute for Polymer Research·JournalJournal of the American Chemical Society·TypeExperimental study·DateSep 8, 2022

Discovery opens way to develop new immunotherapies

Australian researchers have discovered a new mechanism by which T cells can react to lower doses of antigens, leading to a 50-fold increase in T cell activation sensitivity. This finding opens up new possibilities for developing more effective immunotherapies.

SourceMonash University·JournalNature Communications·TypeExperimental study·DateAug 24, 2022

Unlocking cell nucleus behaviors

The discovery reveals that the nucleus deforms like a liquid drop, preserving its shape and protecting its genome. This understanding may lead to new approaches for treating cancer by aiding cell nuclei in regaining their normal shapes.

SourceTexas A&M University·JournalAdvanced Science·DateAug 18, 2022

New understanding of how faulty metabolism triggers adrenal cancer

A new study from the University of Alabama at Birmingham reveals how impaired metabolism due to mutations in succinate dehydrogenase B disables a normal bioenergetic sensing mechanism, leading to uncontrolled cell proliferation. This discovery sheds light on how cancer cells divide despite having a less efficient energy production.

SourceUniversity of Alabama at Birmingham·JournalCell Reports·TypeExperimental study·DateAug 16, 2022

Sugar metabolism is surprisingly conventional in cancer

Researchers at Washington University in St. Louis found that cancer cells metabolize glucose in their mitochondria, following conventional biochemical patterns. The study suggests that limiting glucose uptake may not be an effective strategy to target cancer cells, and glucose metabolism may need to be reevaluated as a therapeutic target.

SourceWashington University in St. Louis·JournalMolecular Cell·TypeExperimental study·DateAug 15, 2022

A smashing solution for cancer therapy

Researchers at Kyoto University have developed a cancer therapy model that utilizes a protein degrading system to transiently degrade and reduce the PD-1 protein, which blocks immune function. This approach has shown high therapeutic efficacy in inhibiting cancer cell growth in mice.

SourceKyoto University·JournalNAR Cancer·TypeExperimental study·DateAug 9, 2022

Using light to restore cell function

University of Cincinnati researchers have discovered a technique using light-activated proteins to normalize dysfunctional mitochondria in cells. This method has the potential to treat certain diseases, including cancer and neurodegenerative disorders.

SourceUniversity of Cincinnati·JournalNature Communications·TypeExperimental study·DateAug 2, 2022

CRISPR therapeutics can damage the genome

A new study from Tel Aviv University found that CRISPR therapeutics can lead to a significant loss of genetic material in treated cells, potentially destabilizing the genome and promoting cancer. The researchers detected up to 10% of cells with lost chromosomes, highlighting the need for extra care when using this technology.

SourceTel-Aviv University·JournalNature Biotechnology·DateJul 24, 2022

With just a tablespoon of blood, B.C. researchers aim to transform cancer treatment

Researchers developed a new blood test that analyzes circulating tumour DNA, providing unprecedented insight into cancer make-up. The test reveals unique characteristics of each patient's cancer, enabling personalized treatment plans. It also sheds light on treatment resistance and helps predict effective treatments.

SourceUniversity of British Columbia·JournalNature·TypeData/statistical analysis·DateJul 20, 2022

Genetic discovery to improve lung cancer treatment

Researchers at Edith Cowan University have found a genetic link between human leukocyte antigens and immunotherapy side effects in non-small cell lung cancer patients. The discovery enables doctors to tailor treatment to individual patients, reducing the risk of toxicities and improving overall outcomes.

SourceEdith Cowan University·JournalEuropean Journal of Cancer·TypeRandomized controlled/clinical trial·DateJul 13, 2022

Programmed cell death in cancer cells: Overcoming resistance through paraptosis-inducing compounds

Researchers from Tokyo University of Science developed novel complex-peptide hybrids that induce programmed cell death in apoptosis-resistant cancer cells through paraptosis. The compounds, syn-6 and anti-6, inhibit cell death by uncoupling mitochondrial calcium uptake and inducing cytoplasmic vacuolization, leading to cell death.

SourceTokyo University of Science·JournalBioconjugate Chemistry·TypeExperimental study·DateJul 11, 2022

Immune cells anchored in tissues offer unique defenses against pathogens and cancers

A new atlas of tissue-resident memory T cells reveals their adaptation to distinct tissue environments, offering insights into immune defense strategies. The study's findings could inform the development of targeted vaccines and therapies, leveraging 'first responders' in tissues vulnerable to infection.

SourceUniversity of California - San Diego·JournalNature Immunology·TypeExperimental study·DateJun 29, 2022

New approach to treatment of deadly kidney cancer

A new study from Karolinska Institutet has identified a key mechanism behind treatment resistance in a deadly form of kidney cancer. By increasing mitochondrial content in cancer cells, researchers found that these cells became susceptible to the cancer drug sorafenib. This breakthrough offers hope for more targeted cancer treatments.

SourceKarolinska Institutet·JournalNature Metabolism·DateJun 27, 2022

App to help doctors help patients with leukemia

Researchers have developed an app to help doctors identify patients with chronic lymphocytic leukemia (CLL) at risk of developing infections, allowing for earlier treatment. The app uses blood test results and genetic data to predict patient risk, improving treatment outcomes and reducing pressure on the healthcare system.

SourceUniversity of Copenhagen - The Faculty of Health and Medical Sciences·JournalCommunications Medicine·TypeCase study·DateJun 24, 2022

Breast cancer spreads at night

Researchers found that circulating cancer cells form metastases mainly during sleep phases, with higher cell division rates at night, suggesting a link between hormone regulation and tumor growth. This discovery highlights the need for healthcare professionals to record the time of biopsies to ensure comparable data.

SourceETH Zurich·JournalNature·TypeExperimental study·DateJun 22, 2022

Estimating tumor-specific total mRNA level predicts cancer outcomes

Researchers developed a mathematical technique to measure total tumor-specific mRNA levels from bulk tumor sequencing data, associating higher mRNA levels with reduced patient survival. The study suggests this approach could serve as a prognostic biomarker for various cancers, guiding treatment selection.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNature Biotechnology·TypeData/statistical analysis·DateJun 13, 2022

AI identifies cancer cells

A new machine learning algorithm called 'ikarus' has found a gene signature characteristic of tumors, distinguishing between healthy and tumor cells in various types of cancer. The algorithm was trained on single-cell sequencing data sets and demonstrated an extraordinarily high success rate in distinguishing between different cell types.

SourceMax Delbrück Center for Molecular Medicine in the Helmholtz Association·JournalGenome Biology·TypeData/statistical analysis·DateJun 10, 2022

Unlocking the mysteries of cell migration

Researchers led by Atsuo Sasaki aim to identify mechanisms behind cell movement and energy allocation in cancer cells, with potential applications beyond cancer treatment. They will use scanning ion-conductance microscopy and machine learning technology to study the role of GTP in cellular migration.

High fat diet, unregulated athletic exercise endurance enhancers linked to risk of pancreatic cancer

A study found that high fat diets and synthetic substances in unregulated athletic performance enhancers can activate a receptor accelerating the progression of pre-cancerous lesions to pancreatic cancer in mice. Limiting exposure to these substances may help prevent pancreatic cancer development.

SourceMichigan Medicine - University of Michigan·JournalNature Communications·TypeExperimental study·DateJun 1, 2022